# SK Capital

SK Capital is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** 430 Park Avenue, 18th Floor, New York, NY 10022, United States
- **Founded:** 2007
- **Assets under management:** Undisclosed
- **Website:** www.skcapitalpartners.com
- **LinkedIn:** https://www.linkedin.com/company/sk-capital-partners
- **Wikidata:** Q104480153

## Regulatory record

- **Reports private funds:** No

## About

SK Capital is a global private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors. It leverages combined expertise in chemistry, operating knowledge, and industry networks to grow and enhance the businesses it invests in. Since founding in 2007, it has raised 7 funds with over $9B in capital commitments and over 20 portfolio companies generating approximately $10B of revenue. It invests from Flagship and Catalyst strategies and works with management to drive transformational growth.

## Sectors

- Specialty Chemicals & Materials
- Life Sciences
- Ingredients

## People

- Barry Siadat — Executive Committee
- Jamshid Keynejad — Executive Committee
- Jack Norris — Executive Committee
- Aaron Davenport — Executive Committee
- Mario Toukan — Executive Committee

## Questions

### Who makes investment decisions at SK Capital?

Investment decisions are made by the Executive Committee, which includes co-founders Barry Siadat and Jamshid Keynejad, along with Managing Directors Jack Norris, Aaron Davenport, and Mario Toukan. The team is built from career operators and investors across the specialty chemicals and pharmaceuticals industries.

### How does SK Capital's two-fund structure work?

SK Capital deploys capital through two programs: the Flagship strategy targets upper mid-market and large companies, while the Catalyst funds, established in 2019, focus on lower mid-market businesses. Both apply the same operational-improvement playbook, but Catalyst is calibrated for smaller, often more complex carve-out or succession-driven situations.

### What kinds of transactions does SK Capital pursue?

The firm executes control buyouts, recapitalizations, growth equity investments, and corporate carve-outs. It gravitates toward situations with operational or technical complexity — divestitures from large corporates, family-owner successions, and underperforming assets — where its in-house operating team can drive a turnaround.

### Where does SK Capital source its proprietary deal flow?

Deal flow originates from decades of relationships in the chemical and pharmaceutical C-suites, corporate carve-out pipelines from industrial conglomerates, and its reputation as a knowledgeable buyer for technically complex businesses. The firm’s team of former plant managers and sector CEOs often identify off-market succession and divestiture opportunities before they reach broader auction.

## Related profiles

- [SK Biopharmaceuticals](https://altss.com/profile/sk-biopharmaceuticals)
- [Skeb](https://altss.com/profile/skeb)

---

Last updated: 2026-08-11T15:08:04.536Z

Canonical page: https://altss.com/profile/sk-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology